Alkermes (ALKS) Construction in Progress (2020 - 2024)
Alkermes (ALKS) posted quarterly Construction in Progress of $30.6 million for Q4 2024, up 955.17% year-over-year from $2.9 million in Q1 2024, and up 955.17% quarter-over-quarter from $2.9 million in Q4 2023.
Alkermes (ALKS) Construction in Progress (2020 - 2024) Analysis & Trends
Alkermes (ALKS) has reported Construction in Progress for 4 consecutive years, with $30.6 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Construction in Progress rose 955.17% year-over-year to $30.6 million; the TTM figure through Dec 2024 stood at $30.6 million (up 955.17% YoY), while the FY2024 annual figure was $30.6 million, up 955.17% from the prior year.
- Construction in Progress grew to $30.6 million in Q4 2024 per ALKS's latest filing, from $2.9 million in the prior quarter.
- Across five years, Construction in Progress topped out at $30.6 million in Q4 2024 and bottomed at $2.9 million in Q4 2023.
- Historically, Construction in Progress has averaged $16.6 million across 4 years, with a median of $16.4 million in 2020.
- On a YoY basis, Construction in Progress climbed as much as 955.17% in 2024 and fell as far as 955.17% in 2024.
- Alkermes' Construction in Progress stood at $24.2 million in 2020, then plunged by 64.05% to $8.7 million in 2022, then slumped by 66.67% to $2.9 million in 2023, then soared by 955.17% to $30.6 million in 2024.
- Business Quant data shows ALKS's Construction in Progress at $30.6 million in Q4 2024, $2.9 million in Q4 2023, and $8.7 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 30.60 Mn |
| Dec 31, 2023 | 2.90 Mn |
| Sep 30, 2022 | 8.70 Mn |
| Dec 31, 2020 | 24.20 Mn |